A blood clot removal method for removing blood clots from the vascular system of a patient, the blood clot removal method carried out on an implantable device in the patient's body and comprising: allowing a blood flow through a passageway between a first side wall and a second side wall, filtering blood clots with a filter provided in the blood flow passageway, and cleaning the filter with a cleaning device, wherein the cleaning device is moved from the first side wall towards the second side wall to move blood clots away from the blood flow passageway.

A blood analysis system for analysis and correction of blood of a subject includes a centrifugation unit to receive blood of a subject. The centrifugation unit is configured to hold capturing molecules for chemical capture of molecules and/or ions that deactivate at least one of coagulation and complement pathways in the blood and centrifuge to suspend cellular components with a minimal plasma along with the capturing molecules. The blood analysis system includes a correction unit coupled to the centrifugation unit to receive the minimal plasma having the capturing molecules and the cellular components from the centrifugation unit. The correction unit is configured to extract the capturing molecules from the minimal plasma, prior to infusing the minimal plasma having the cellular components along with replaced captured molecules and/or ions back to the subject and discarding the extracted capturing molecules.

A method and system for treating, by filtration, haemorrhagic fluid contained in a container with a view to subsequent autotransfusion, including at least one step of concentrating by filtration said haemorrhagic fluid in order to increase the concentration of red blood cells in the haemorrhagic fluid to reach a target haematocrit level while at the same time removing from the haemorrhagic fluid a filtrate comprising compounds not desired for autotransfusion, further including: a preliminary step of measuring the haematocrit level of the haemorrhagic fluid; and a dilution step consisting in adding to the volume of haemorrhagic fluid to be treated a determined volume of dilution fluid, the determined volume of dilution fluid being calculated as a function of the measured haematocrit level of the haemorrhagic fluid and the target haematocrit level.

An implantable drainage device is provided. The device is adapted to move body fluid from one part of the body of a patient to another part of the body.

A blood clot removal device for removing blood clots from the vascular system of a patient is implantable in the patient's body. The blood clot removal device comprises a blood flow passageway to be connected to the patient's vascular system to allow circulation of the patient's blood through the blood flow passageway, a filter provided in the blood flow passageway for collecting blood clots occurring in the blood flowing through the blood flow passageway, and a cleaning device for moving blood clots collected by the filter out of the blood flow passageway. By means of such blood clot removal device, the risk of blood clots reaching sensitive areas of the patient's body, such as the brain, is reduced.

Bulbs for use with an IV set are described herein. A bulb includes a bulb body and a filter. The bulb body defines an inlet, an outlet, and a bulb volume in fluid communication with the inlet and the outlet. The filter is in fluid communication with the bulb volume. The filter captures particulate from a flow from the inlet to the outlet. The bulb body is deformable to compress the bulb volume and direct back flow from the bulb volume through the filter, agitating particulate captured in the filter, unclogging the filter and allowing for more flow.

IV filters are described herein. An IV filter includes a body, a filter media, and a bulb. The body defines a body volume. The filter media is disposed within the body volume. The filter media defines an inlet portion of the body volume and an outlet portion of the body volume. The filter media permits inlet flow from the inlet portion of the body volume to the outlet portion of the body volume and captures particulate from the inlet flow. The bulb defines a bulb volume in fluid communication with the outlet portion of the body volume. The bulb is deformable to compress the bulb volume and direct back flow from the outlet portion of the body volume through the filter media and into the inlet portion of the body volume, displacing particulate captured in the filter media into the inlet portion of the body volume.

The invention relates to an intravascular blood pump. The blood pump comprises a pump section having a proximal portion with a blood flow inlet and a distal portion with a blood flow outlet and an impeller for causing blood to flow into the blood flow inlet and towards the blood flow outlet. The blood pump further comprises at least one filter connected to the proximal portion of the pump section and arranged with respect to the blood flow inlet so as to filter the blood before it enters the blood flow inlet. The filter may comprise an expandable mesh structure made of a shape-memory material.

The present invention relates to an apheresis device (1) for the extracorporeal removal of C-reactive protein from blood of a patient, wherein the apheresis device is connectable to the blood circulation of the patient. The blood is pumped via a part of the extracorporeal circulation system (2) of the apheresis device (1) according to the invention to a cell separator (7) for separation of the blood into blood plasma and cellular components. Via a first outlet of the cell separator (7), the separated blood plasma is directed by means of a plasma line (8A) to an apheresis column (4) for affinity chromatographic removal of C-reactive protein from the blood plasma. After removal of the C-reactive protein from the blood plasma of the patient, said now treated blood plasma is combined with the cellular components of the blood via a plasma line (8B). Furthermore, the apheresis device (1) according to the invention comprises a bypass line (12), which leads from the plasma line (8A) into the plasma line (8B) while bypassing the apheresis column (4). The apheresis device (1) according to the invention also comprises a regeneration line (14), which runs into the plasma line (8A) or directly into the apheresis column (4).

The present invention relates to a filtering device for removing particles from a bodily fluid of a patient, the filtering device being implantable in the patient's body. The device has a tube forming a main fluid passageway for bodily fluid, through which the bodily fluid of the patient passes when the tube is implanted in the patient, a filter connected to the tube and a filter cleaning device for cleaning the filter by moving particles collected by the filter out of the fluid passageway, wherein the filter cleaning device is adapted to replace the first filter in the fluid passageway with a second filter, thereby moving the particles collected by the first filter out of the fluid passageway.